Submission Details
| 510(k) Number | K153303 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 16, 2015 |
| Decision Date | August 10, 2016 |
| Days to Decision | 268 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K153303 is an FDA 510(k) clearance for the EUROIMMUN Anti-West Nile Virus ELISA (IgG), a Elisa, Antibody, West Nile Virus (Class II — Special Controls, product code NOP), submitted by Euroimmun Us, Inc. (Morris Plains, US). The FDA issued a Cleared decision on August 10, 2016, 268 days after receiving the submission on November 16, 2015. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3940.
| 510(k) Number | K153303 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 16, 2015 |
| Decision Date | August 10, 2016 |
| Days to Decision | 268 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | NOP — Elisa, Antibody, West Nile Virus |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3940 |
| Definition | The West Nile Virus Elisa Is Intended For The Detection Of Igg And Igm Antibodies To West Nile Virus. Specimens May Be Serum Or Cerebral Spinal Fluid From Symptomatic Patients. |